Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
Clinical trial NCT04975711 · COMPLETED
Trial details
- NCT number
- NCT04975711
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-12
- Primary completion
- 2021-11-03
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.